CGP 52432
Tocris Bioscience, part of Bio-Techne | Catalog # 1246
Potent and selective GABAB antagonist
Key Product Details
Description
Potent and selective GABAB antagonist
Product Description
CGP 52432 is a potent, selective GABAB receptor antagonist (IC50 = 85 nM).Licensing Information
Sold with the permission of Novartis Pharma AGProduct Specifications
Molecular Weight
384.24
Formula
C15H24Cl2NO4P
Storage
Store at +4°C
Purity
≥98% (HPLC)
Chemical Name
3-[[(3,4-Dichlorophenyl)methyl]amino]propyl] diethoxymethyl)phosphinic acid
CAS Number
139667-74-6
PubChem ID
132252
InChI Key
GJZVQXWEIYRHBE-UHFFFAOYSA-N
SMILES
ClC1=CC=C(CNCCCP(C(OCC)OCC)(O)=O)C=C1Cl
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 1.92 | 5 |
Preparing Stock Solutions
for CGP 52432
The following data is based on the product molecular weight 384.24
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.05 mM | 52.05 mL | 260.25 mL | 520.51 mL |
| 0.25 mM | 10.41 mL | 52.05 mL | 104.10 mL |
| 0.5 mM | 5.21 mL | 26.03 mL | 52.05 mL |
| 2.5 mM | 1.04 mL | 5.21 mL | 10.41 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Froestl Potent, orally active GABAB receptor antagonists. Pharmacol.Rev.Comm.
- Lanza CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. Eur.J.Pharmacol. 1993 PMID: 8103461
- Libri Blockade of GABAB receptors facilitates muscarinic agonist-induced epileptiform activity in immature rat piriform cortex in vitro. Naunyn Schmiedebergs Arch.Pharmacol. 1998 PMID: 9750001
- Bonanno GABAB receptors as potential targets for drugs able to prevent excessive excitatory amino acid transmission in the spinal cord. Eur.J.Pharmacol. 1998 PMID: 9874164
Product Specific Notices for CGP 52432
For research use only
Loading...
Loading...
Loading...